Related references
Note: Only part of the references are listed.The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan
Eric Sanchez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Proteasome Inhibitors: Recent Advances and New Perspectives In Medicinal Chemistry
E. Genin et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
The 26S proteasome: assembly and function of a destructive machine
Nerea Gallastegui et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome
Francesco Parlati et al.
BLOOD (2009)
The persisting challenge of selective and specific proteasome inhibition
Michael Groll et al.
JOURNAL OF PEPTIDE SCIENCE (2009)
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis
Tony Muchamuel et al.
NATURE MEDICINE (2009)
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
Andreas A. Argyriou et al.
BLOOD (2008)
Proteasome inhibitors: Poison's and remedies
Silke Meiners et al.
MEDICINAL RESEARCH REVIEWS (2008)
Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome
Susan D. Demo et al.
CANCER RESEARCH (2007)
Diversity of proteasomal missions: fine tuning of the immune response
Ljudmila Borissenko et al.
BIOLOGICAL CHEMISTRY (2007)
20S proteasome and its inhibitors: Crystallographic knowledge for drug development
Ljudmila Borissenko et al.
CHEMICAL REVIEWS (2007)
Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132
Lisa J. A. Crawford et al.
CANCER RESEARCH (2006)
Crystal structures of salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of β-lactone ring opening and a mechanism for irreversible binding
M Groll et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Ionisations within a subtilisin-glyoxal inhibitor complex
A Djurdjevic-Pahl et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora
RH Feling et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Crystal structure of epoxomicin:20S proteasome reveals a molecular basis for selectivity of α′,β′-epoxyketone proteasome inhibitors
M Groll et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Share Paper
